Ray Dalio’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Sell
149,257
-99,925
-40% -$1.74M 0.01% 524
2025
Q4
$2.94M Sell
249,182
-20,429
-8% -$262K 0.01% 675
2025
Q3
$4.27M Buy
+269,611
New +$3.91M 0.02% 526
2024
Q3
Sell
-103,654
Closed -$2.34M 795
2024
Q2
$2.34M Sell
103,654
-136,461
-57% -$3.57M 0.01% 502
2024
Q1
$6.31M Buy
240,115
+61,396
+34% +$1.75M 0.03% 339
2023
Q4
$5.64M Sell
178,719
-80,216
-31% -$2.18M 0.03% 350
2023
Q3
$7.26M Buy
258,935
+189,456
+273% +$6.5M 0.04% 289
2023
Q2
$2.56M Buy
69,479
+7,131
+11% +$218K 0.02% 430
2023
Q1
$1.87M Sell
62,348
-56,951
-48% -$1.88M 0.01% 468
2022
Q4
$3.65M Buy
+119,299
New +$3.58M 0.02% 421
2022
Q2
Sell
-34,393
Closed -$1.08M 1003
2022
Q1
$1.08M Buy
+34,393
New +$1.08M ﹤0.01% 790
2021
Q1
Sell
-20,277
Closed -$503K 480
2020
Q4
$503K Buy
20,277
+3,871
+24% +$92.1K ﹤0.01% 462
2020
Q3
$343K Buy
+16,406
New +$317K ﹤0.01% 419

Other funds holding CC

Ray Dalio's CC Position: Q1 2026 in Review

Ray Dalio reduced its Chemours (CC) stake by 40% in Q1 2026, selling an estimated $1.74M and leaving 149,257 shares worth $3.29M. The position accounts for 0.01% of the portfolio, ranked #524.

Ray Dalio first reported a position in CC in Q3 2020 and has held it in 13 quarters since. The position peaked at $7.26M in Q3 2023. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Ray Dalio held 149,257 shares of Chemours worth $3.29M as of Q1 2026.
  • Ray Dalio sold 99,925 Chemours shares in Q1 2026, an estimated $1.74M.
  • Chemours made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #524 holding.
  • Ray Dalio first reported a position in Chemours in Q3 2020 and has held it in 13 quarters since.
  • Ray Dalio's Chemours position peaked at $7.26M in Q3 2023.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.